21:46:19 EST Wed 18 Feb 2026
Enter Symbol
or Name
USA
CA



NUTRIEN LTD.
Symbol NTR
Shares Issued 481,436,166
Close 2026-02-18 C$ 96.33
Market Cap C$ 46,376,745,871
Recent Sedar+ Documents

Nutrien Reports Full-Year 2025 Results and Provides 2026 Guidance

2026-02-18 17:26 ET - News Release

  • Full-year results demonstrate strong execution of our strategic plan and progress towards 2026 performance targets.
  • 2026 guidance reflects growth in upstream fertilizer sales volumes from our North American plants, higher Retail earnings, and a disciplined and consistent approach to capital allocation.

All amounts are in US dollars, except as otherwise noted


Company Website: https://www.nutrien.com
SASKATOON, Saskatchewan -- (Business Wire)

Nutrien Ltd. (TSX and NYSE: NTR) announced today its fourth quarter 2025 results, with net earnings of $0.58 billion ($1.18 diluted net earnings per share). Fourth quarter 2025 adjusted EBITDA1 was $1.28 billion and adjusted net earnings per share1 was $0.83.

“2025 was a defining year for our Company, with exceptional performance across all our operating segments and a reduction in cost and capital expenditures that surpassed our targets. Alongside delivering structural free cash flow growth, we took decisive actions to optimize our portfolio, strengthen our balance sheet and increase cash returns to shareholders,” commented Ken Seitz, Nutrien’s President and CEO.

“As we move into 2026, our priorities remain unchanged and we expect to build on our momentum supported by strong potash market fundamentals, an improved Nitrogen margin profile, and higher Retail earnings. I am excited about Nutrien’s extraordinary potential as we continue to position the Company for long-term growth and resilience,” added Mr. Seitz.

Highlights2:

  • Generated net earnings of $2.30 billion and adjusted EBITDA of $6.05 billion for the full year of 2025. Adjusted EBITDA increased due to higher fertilizer net selling prices, record upstream fertilizer sales volumes and higher Retail earnings.
  • Generated strong free cash flow in 2025 and approximately $900 million in gross proceeds from asset divestiture proceeds since the fourth quarter of 2024, enabling a reduction in adjusted net debt and a 30 percent increase in total cash returns to shareholders.3
  • Retail adjusted EBITDA increased to $1.74 billion in 2025 due to lower operating expenses from our cost savings initiatives, stronger proprietary products gross margin and disciplined execution of our Brazil margin improvement plan. We continue to simplify our business and deliver earnings growth through proven organic initiatives.
  • Potash adjusted EBITDA increased to $2.25 billion in 2025 due to higher net selling prices and record sales volumes, supported by strong potash affordability and underlying consumption growth in key offshore markets. We mined 49 percent of our potash ore tonnes using automation, further strengthening our low-cost advantage.
  • Nitrogen adjusted EBITDA increased to $2.15 billion in 2025 due to higher net selling prices. Total ammonia production increased in 2025, supported by a four-percentage-point improvement in ammonia operating rate4 as we advanced reliability initiatives across our North American plants and completed low-cost debottlenecks at Redwater and Geismar.
  • We repurchased approximately 2 percent of our shares outstanding in 2025 for a total of $551 million. Nutrien’s Board of Directors approved a 1 percent increase in the quarterly dividend to $0.55 per share and approved the purchase of up to 5 percent of outstanding common shares over a twelve-month period through a normal course issuer bid (“NCIB”). The NCIB is subject to acceptance by the Toronto Stock Exchange.

1

This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section. All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.

2

Our discussion of highlights set out on this page is a comparison of the results for the twelve months ended December 31, 2025 to the results for the twelve months ended December 31, 2024, unless otherwise noted.

3

Cash used for dividends and share repurchases.

4

Excludes Trinidad and Joffre.

Update on Strategic Actions:

We continue to take actions to simplify our portfolio and focus on core assets to enhance earnings quality and free cash flow.

  • On December 10, 2025, we completed the sale of our 50 percent equity interest in Profertil S.A. (“Profertil”) for approximately $0.6 billion. Since initiating portfolio actions in the fourth quarter of 2024, Nutrien has generated approximately $900 million in gross proceeds, enhancing capital efficiency and portfolio resilience while strengthening the balance sheet and increasing cash returns to shareholders.
  • We are progressing as planned with the review of strategic alternatives for our Phosphate business and intend to solidify the optimal path in 2026.
  • We continue to assess options for our Trinidad Nitrogen facility, and consistent with our approach of reviewing non-core assets, we ceased production at our New Madrid Nitrogen upgrade facility at year-end 2025. Our Trinidad and New Madrid plants combined accounted for approximately 1.6 million tonnes of Nitrogen sales volumes in 2025, however contributed marginal free cash flow. These portfolio actions improve the margin profile of our Nitrogen business, allow for greater focus on enhancing our core North American assets, and provide increased stability to consolidated free cash flow.



Market Outlook and Guidance

Agriculture and Retail Markets

  • Higher global grain and oilseed production in 2025 increased stocks-to-use ratios towards historical average levels and led to significant nutrient removal from the soil. Strong demand for food, feed and biofuel uses is expected to drive continued need for higher global crop production and related crop inputs.
  • We expect total US crop acres in 2026 to be consistent with 2025 levels and project corn plantings of 94 to 96 million acres and soybean plantings of 84 to 86 million acres. This acreage outlook, combined with a compressed fertilizer application season in the fall of 2025, is expected to support increased crop input demand in the first half of 2026.
  • In Brazil, soybean production is expected to set another record in 2026, with harvest currently underway, and we anticipate a 3 to 5 percent increase in safrinha corn plantings. Growth in planted area is expected to support crop input demand; however, weaker affordability is expected to result in just-in-time purchases and a continued shift to lower analysis nitrogen and phosphate products.
  • In Australia, improved weather compared to the first half of 2025 is expected to support crop input demand and strong livestock prices to support sales of Retail products and services.

Crop Nutrient Markets

  • Global potash shipments increased to approximately 74.5 million tonnes in 2025, primarily driven by strong demand in Southeast Asia. We expect a fourth consecutive year of growth in 2026, with total global potash shipments ranging between 74 and 77 million tonnes. Demand is supported by the need to replenish soil nutrients following a record crop, favorable relative affordability and low inventory levels in key markets such as China and Brazil. We anticipate relatively tight fundamentals throughout 2026, as trend line demand growth is testing existing global operating and supply chain capabilities.
  • Global nitrogen demand is expected to grow in line with historical rates, driven by increasing use in agricultural growth markets such as Asia and Latin America. Global ammonia markets remain tight due to project delays and plant outages. Global urea markets have strengthened in the first quarter of 2026 due to strong seasonal demand from India, North America and Brazil and geopolitical uncertainties impacting supply.
  • Global phosphate markets eased in the fourth quarter of 2025 due to lower demand related to weaker affordability relative to potash and nitrogen. Phosphate markets have strengthened in the first quarter of 2026 due to Chinese export restrictions and elevated input costs.

Financial and Operational Guidance

  • Retail adjusted EBITDA guidance of $1.75 to $1.95 billion represents continued structural growth in our downstream business consistent with historical rates. The mid-point of our guidance range assumes high-single digit growth in proprietary products gross margins, a mid-single digit increase in our North American crop nutrient sales volumes, improved weather conditions in Australia and cost reduction initiatives across all geographies.
  • Potash sales volume guidance of 14.1 to 14.8 million tonnes is consistent with our global shipment expectation.
  • Nitrogen sales volume guidance of 9.2 to 9.7 million tonnes assumes no production from our Trinidad and New Madrid facility, which accounted for approximately 1.4 million tonnes and 0.2 million tonnes, respectively, in 2025. Nitrogen sales volumes are supported by planned reliability improvements and debottlenecks.
  • Phosphate sales volume guidance of 2.4 to 2.6 million tonnes reflect the benefits of reliability improvement initiatives completed in 2025.
  • Total capital expenditures of $2.0 to $2.1 billion is consistent with 2025 as we continue to optimize capital to sustain safe and reliable operations and to progress a set of targeted growth investments. The total includes approximately $400 million in investing capital focused on proprietary products, network optimization and digital capabilities in Retail, low-cost brownfield expansions and product optimization projects in Nitrogen, and mine automation in Potash.

All guidance numbers, including those noted above, are outlined in the table below. In addition, set forth below are anticipated fertilizer pricing and natural gas price sensitivities relating to adjusted EBITDA (consolidated) and adjusted net earnings per share.

 

2026 Guidance ranges1 as of
February 18, 2026

 

($ billions, except as otherwise noted)

Low

High

2025 Actual

Retail adjusted EBITDA

1.75

1.95

1.74

Potash sales volumes (million tonnes) 2

14.1

14.8

14.25

 

Nitrogen sales volumes (million tonnes) 2

9.2

9.7

10.89

Phosphate sales volumes (million tonnes) 2

2.4

2.6

2.36

Depreciation and amortization

2.4

2.5

2.4

Finance costs

0.65

0.75

0.7

Effective tax rate on adjusted net earnings (%) 3

24.0

26.0

24.9

Capital expenditures 4

2.0

2.1

2.0

1 See the “Forward-Looking Statements” section.

2 Manufactured product only.

3 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

4 Comprised of sustaining capital expenditures, investing capital expenditures and mine development and pre-stripping capital expenditures, which are supplementary financial measures. See the “Other Financial Measures” section.

2026 Annual Sensitivities

Effect on1

($ millions, except EPS amounts)

Adjusted EBITDA

Adjusted EPS4

$25 per tonne change in potash net selling prices

± 280

± 0.45

$25 per tonne change in ammonia net selling prices 2

± 35

± 0.05

$25 per tonne change in urea and ESN® net selling prices

± 65

± 0.10

$25 per tonne change in solutions, nitrates and sulfates net selling prices

± 135

± 0.20

$1 per MMBtu change in NYMEX natural gas price 3

± 180

± 0.30

1 See the “Forward-Looking Statements” section.

2 Excludes Trinidad.

3 Nitrogen related impact.

4 Based on shares outstanding as at December 31, 2025.

 
 

Consolidated Results

 

Three Months Ended December 31

 

Twelve Months Ended December 31

($ millions, except as otherwise noted)

2025

2024

% Change

 

2025

2024

% Change

Sales

5,340

5,079

5

 

26,885

25,972

4

Gross margin

1,888

1,581

19

 

8,347

7,530

11

Expenses

967

1,184

(18)

 

4,611

5,674

(19)

Net earnings

580

118

392

 

2,297

700

228

Adjusted EBITDA 1

1,277

1,055

21

 

6,046

5,355

13

Diluted net earnings per share (dollars) 2

1.18

0.23

413

 

4.66

1.36

243

Adjusted net earnings per share (dollars) 1, 2

0.83

0.31

168

 

4.56

3.47

31

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

2 All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted.

Net earnings and adjusted EBITDA increased in the fourth quarter primarily due to higher fertilizer net selling prices and Potash sales volumes, partially offset by lower Nitrogen sales volumes and Retail earnings. For the full year of 2025, net earnings and adjusted EBITDA increased due to higher fertilizer net selling prices, increased upstream fertilizer sales volumes and higher Retail earnings. Net earnings for the fourth quarter of 2025 were positively impacted by the gain on sale of investment related to the disposal of our 50 percent equity ownership in Profertil.



Segment Results

Our discussion of segment results set out on the following pages is a comparison of the results for the three and twelve months ended December 31, 2025 to the results for the three and twelve months ended December 31, 2024, unless otherwise noted.

Retail

 

Three Months Ended December 31

 

Twelve Months Ended December 31

($ millions, except as otherwise noted)

2025

2024

% Change

 

2025

2024

% Change

Sales

3,144

3,179

(1)

 

17,620

17,832

(1)

Cost of goods sold

2,167

2,193

(1)

 

13,017

13,211

(1)

Gross margin

977

986

(1)

 

4,603

4,621

Adjusted EBITDA 1

311

340

(9)

 

1,736

1,696

2

1 See Note 2 to the interim financial statements.

  • Retail adjusted EBITDA decreased in the fourth quarter as the prior period benefited from other income items, most notably a $25 million gain on sale of land in Argentina. Adjusted EBITDA increased for the full year of 2025 due to lower operating expenses from our cost savings initiatives, higher proprietary products gross margin and strategic actions related to our Brazil margin improvement plan.

 

Three Months Ended December 31

 

Twelve Months Ended December 31

 

Sales

 

Gross Margin

 

Sales

 

Gross Margin

($ millions)

2025

2024

 

2025

2024

 

2025

2024

 

2025

2024

Crop nutrients

1,512

1,528

 

288

294

 

7,285

7,211

 

1,424

1,444

Crop protection products

931

948

 

324

351

 

6,105

6,313

 

1,590

1,622

Seed

162

184

 

48

52

 

2,128

2,235

 

408

431

Services and other

254

228

 

219

188

 

944

918

 

750

716

Merchandise

226

230

 

39

40

 

875

897

 

148

150

Nutrien Financial

82

77

 

82

77

 

376

361

 

376

361

Nutrien Financial elimination 1

(23)

(16)

 

(23)

(16)

 

(93)

(103)

 

(93)

(103)

Total

3,144

3,179

 

977

986

 

17,620

17,832

 

4,603

4,621

1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

  • Crop nutrients sales and gross margin decreased in the fourth quarter of 2025 due to lower sales volumes from a weather-shortened fall application window in the US and reduced demand for phosphate, partially offset by higher proprietary products gross margin. For the full year of 2025, sales increased due to higher selling prices, and gross margin was impacted by product mix shifts in North America and reduced demand in the fourth quarter. International crop nutrient sales volumes were lower in the fourth quarter and full year of 2025 mainly due to strategic actions in South America.
  • Crop protection products sales and gross margin were lower in the fourth quarter and full year of 2025 due to product mix shifts in North America and dry conditions in Australia, partially offset by higher proprietary products gross margin.
  • Seed sales and gross margin decreased in the fourth quarter due to strategic actions in South America. Sales and gross margin were lower for the full year of 2025 due to weather related impacts in the Southern US leading to fewer planted acres which impacted proprietary products gross margin.

Supplemental Data

Three Months Ended December 31

 

Twelve Months Ended December 31

 

Gross Margin

 

% of Product Line 1

 

Gross Margin

 

% of Product Line 1

($ millions, except as otherwise noted)

2025

2024

 

2025

2024

 

2025

2024

 

2025

2024

Proprietary products

 

 

 

 

 

 

 

 

 

 

 

Crop nutrients

65

60

 

22

19

 

450

421

 

32

29

Crop protection products

43

41

 

13

11

 

503

470

 

32

29

Seed

7

6

 

18

16

 

137

154

 

34

36

Merchandise

4

4

 

9

9

 

14

15

 

9

10

Total

119

111

 

12

11

 

1,104

1,060

 

24

23

1 Represents percentage of proprietary product margins over total product line gross margin.

Three Months Ended December 31

 

Twelve Months Ended December 31

 

Sales Volumes
(tonnes - thousands)

 

Gross Margin / Tonne
(dollars)

 

Sales Volumes
(tonnes - thousands)

 

Gross Margin / Tonne
(dollars)

 

2025

2024

 

2025

2024

 

2025

2024

 

2025

2024

Crop nutrients

 

 

 

 

 

 

 

 

 

 

 

North America

1,600

1,854

 

137

125

 

8,502

8,547

 

143

142

International

626

716

 

108

87

 

3,358

3,715

 

61

62

Total

2,226

2,570

 

129

114

 

11,860

12,262

 

120

118

 

(percentages)

December 31, 2025

 

December 31, 2024

Financial performance measures 1, 2

 

 

 

Cash operating coverage ratio

62

 

63

Average working capital to sales

22

 

20

Average working capital to sales excluding Nutrien Financial

1

 

-

Nutrien Financial adjusted net interest margin

5.4

 

5.3

1 Rolling four quarters.

2 These are non-GAAP financial measures. See the “Non-GAAP Financial Measures” section.

Potash

 

Three Months Ended December 31

 

Twelve Months Ended December 31

($ millions, except as otherwise noted)

2025

 

2024

% Change

 

2025

 

2024

% Change

Net sales

736

 

536

37

 

3,593

 

2,989

20

Cost of goods sold

324

 

309

5

 

1,581

 

1,448

9

Gross margin

412

 

227

81

 

2,012

 

1,541

31

Adjusted EBITDA 1

445

 

291

53

 

2,254

 

1,848

22

1 See Note 2 to the interim financial statements.

  • Potash adjusted EBITDA increased in the fourth quarter and full year of 2025 due to higher net selling prices and higher sales volumes, partially offset by higher provincial mining taxes. Total and offshore sales volumes in 2025 were the highest on record.

Manufactured Product

Three Months Ended
December 31

 

Twelve Months Ended
December 31

($ per tonne, except as otherwise noted)

2025

 

2024

 

2025

 

2024

Sales volumes (tonnes - thousands)

 

 

 

 

 

 

 

North America

726

 

718

 

4,638

 

4,672

Offshore

2,077

 

2,040

 

9,615

 

9,214

Total sales volumes

2,803

 

2,758

 

14,253

 

13,886

Net selling price

 

 

 

 

 

 

 

North America

305

 

270

 

286

 

285

Offshore

247

 

168

 

235

 

180

Average net selling price

262

 

194

 

252

 

215

Cost of goods sold

115

 

112

 

111

 

104

Gross margin

147

 

82

 

141

 

111

Depreciation and amortization

45

 

49

 

46

 

44

Gross margin excluding depreciation and amortization 1

192

 

131

 

187

 

155

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

  • Sales volumes were higher in the fourth quarter and full year of 2025 compared to the same periods in 2024. Higher offshore sales volumes were supported by strong potash affordability and underlying consumption growth in key offshore markets. North America sales volumes in the fourth quarter and full year of 2025 were consistent to the same periods in 2024.
  • Net selling priceper tonne increased in the fourth quarter and full year of 2025 due to higher global benchmark prices.
  • Cost of goods sold per tonne increased in the fourth quarter and full year of 2025 primarily due to higher royalties and maintenance costs, with the full year also impacted by higher depreciation.

Supplemental Data

Three Months Ended
December 31

 

Twelve Months Ended
December 31

 

2025

 

2024

 

2025

 

2024

Production volumes (tonnes – thousands)

3,539

 

3,369

 

13,966

 

14,205

Potash controllable cash cost of product manufactured per tonne 1

61

 

59

 

58

 

54

Canpotex sales by market (percentage of sales volumes) 2

 

 

 

 

 

 

 

Latin America

35

 

35

 

39

 

40

Other Asian markets 3

26

 

24

 

29

 

28

China

13

 

16

 

11

 

13

India

11

 

11

 

6

 

7

Other markets

15

 

14

 

15

 

12

Total

100

 

100

 

100

 

100

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

2 See Note 10 to the interim financial statements.

3 All Asian markets except China and India.

Nitrogen

 

Three Months Ended December 31

 

Twelve Months Ended December 31

($ millions, except as otherwise noted)

2025

 

20241,2

% Change

 

2025

 

20241,2

% Change

Net sales

1,093

 

981

11

 

4,187

 

3,576

17

Cost of goods sold

682

 

669

2

 

2,580

 

2,374

9

Gross margin

411

 

312

32

 

1,607

 

1,202

34

Adjusted EBITDA 2

521

 

471

11

 

2,147

 

1,880

14

1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

2 See Note 2 to the interim financial statements.

  • Nitrogen adjusted EBITDA increased in the fourth quarter and the full year of 2025 due to higher net selling prices, partially offset by lower equity earnings from Profertil. Adjusted EBITDA for the full year of 2024 benefitted from insurance recoveries. Total ammonia production increased in 2025, supported by a four-percentage-point improvement in ammonia operating rate as we advanced reliability initiatives across our North American plants and completed low-cost debottlenecks at Redwater and Geismar.

Manufactured Product

Three Months Ended
December 31

 

Twelve Months Ended
December 31

($ per tonne, except as otherwise noted)

2025

 

2024

 

2025

 

2024

Sales volumes (tonnes - thousands)

 

 

 

 

 

 

 

Ammonia

546

 

701

 

2,420

 

2,483

Urea and ESN®

656

 

888

 

3,099

 

3,188

Solutions, nitrates and sulfates

1,373

 

1,325

 

5,369

 

5,023

Total sales volumes

2,575

 

2,914

 

10,888

 

10,694

Net selling price

 

 

 

 

 

 

 

Ammonia

470

 

448

 

422

 

410

Urea and ESN®

505

 

403

 

490

 

421

Solutions, nitrates and sulfates

272

 

213

 

268

 

221

Average net selling price

373

 

327

 

365

 

324

Cost of goods sold

214

 

221

 

219

 

213

Gross margin

159

 

106

 

146

 

111

Depreciation and amortization

59

 

58

 

57

 

55

Gross margin excluding depreciation and amortization 1

218

 

164

 

203

 

166

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

 
  • Sales volumes decreased in the fourth quarter of 2025 due to the previously announced controlled shutdown of our Trinidad facility on October 23, 2025 and planned turnarounds at our North American operations. Sales volumes increased for the full year of 2025 due to higher production from reliability improvements and low-cost debottlenecks that increased the availability of upgraded products.
  • Net selling price per tonne was higher in the fourth quarter and full year of 2025 for all major nitrogen products due to stronger benchmark prices.
  • Cost of goods sold per tonne decreased in the fourth quarter of 2025 due to a higher percentage of sales coming from our low-cost North American nitrogen plants. For the full year of 2025, cost of goods sold per tonne increased compared to the prior year due to higher natural gas costs, mainly driven by Henry Hub benchmark.

Supplemental Data

Three Months Ended
December 31

 

Twelve Months Ended
December 31

 

2025

 

2024

 

2025

 

2024

Sales volumes (tonnes – thousands)

 

 

 

 

 

 

 

Fertilizer

1,545

 

1,801

 

6,425

 

6,259

Industrial and feed

1,030

 

1,113

 

4,463

 

4,435

Production volumes (tonnes – thousands)

 

 

 

 

 

 

 

Ammonia production – total 1

1,192

 

1,451

 

5,706

 

5,608

Ammonia production – adjusted 1, 2

1,004

 

1,041

 

4,135

 

3,953

Ammonia operating rate (%) 2

89

 

92

 

92

 

88

Natural gas costs (dollars per MMBtu)

 

 

 

 

 

 

 

Overall natural gas cost excluding realized derivative impact

3.31

 

3.56

 

3.53

 

3.15

Realized derivative impact 3

 

0.10

 

 

0.09

Overall natural gas cost

3.31

 

3.66

 

3.53

 

3.24

1 All figures are provided on a gross production basis in thousands of product tonnes.

2 Excludes Trinidad and Joffre.

3 Includes realized derivative impacts recorded as part of cost of goods sold or other income and expenses. Refer to Note 4 to the interim financial statements.

Phosphate

 

Three Months Ended December 31

 

Twelve Months Ended December 31

($ millions, except as otherwise noted)

2025

 

2024

% Change

 

2025

 

2024

% Change

Net sales

483

 

414

17

 

1,734

 

1,657

5

Cost of goods sold

430

 

394

9

 

1,590

 

1,510

5

Gross margin

53

 

20

165

 

144

 

147

(2)

Adjusted EBITDA 1

107

 

86

24

 

382

 

384

(1)

1 See Note 2 to the interim financial statements.

  • Phosphate adjusted EBITDA increased in the fourth quarter of 2025 due to higher net selling prices and sales volumes, partially offset by higher sulfur input costs. Adjusted EBITDA slightly decreased for the full year of 2025 due to higher sulfur input costs and lower sales volumes, partially offset by higher net selling prices.

Manufactured Product

Three Months Ended
December 31

 

Twelve Months Ended
December 31

($ per tonne, except as otherwise noted)

2025

 

2024

 

2025

 

2024

Sales volumes (tonnes - thousands)

 

 

 

 

 

 

 

Fertilizer

468

 

435

 

1,646

 

1,751

Industrial and feed

186

 

173

 

717

 

683

Total sales volumes

654

 

608

 

2,363

 

2,434

Net selling price

 

 

 

 

 

 

 

Fertilizer

677

 

615

 

677

 

612

Industrial and feed

875

 

812

 

835

 

822

Average net selling price

733

 

671

 

725

 

671

Cost of goods sold

646

 

631

 

657

 

603

Gross margin

87

 

40

 

68

 

68

Depreciation and amortization

112

 

127

 

121

 

119

Gross margin excluding depreciation and amortization 1

199

 

167

 

189

 

187

1 This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

 
  • Sales volumes were higher in the fourth quarter of 2025 due to higher production from reliability improvements and weather-related events that impacted the fourth quarter of 2024 production volumes, partially offset by reduced demand for phosphate. Sales volumes were lower for the full year due to lower production volumes in the first quarter of 2025.
  • Net selling price per tonne increased in the fourth quarter and full year of 2025 due to the strength of fertilizer benchmark prices.
  • Cost of goods sold per tonne increased in the fourth quarter and full year of 2025 primarily due to higher sulfur input costs.

Supplemental Data

Three Months Ended
December 31

 

Twelve Months Ended
December 31

 

2025

 

2024

 

2025

 

2024

Production volumes (P2O5 tonnes – thousands)

367

 

319

 

1,360

 

1,327

P2O5 operating rate (%)

86

 

75

 

80

 

78

 
 

Corporate and Others and Eliminations

 

Three Months Ended December 31

 

Twelve Months Ended December 31

($ millions, except as otherwise noted)

2025

 

20241, 2

 

% Change

 

2025

 

20241, 2

 

% Change

Corporate and Others

 

 

 

 

 

 

 

 

 

 

 

Gross margin 2

7

 

14

 

(50)

 

27

 

21

 

29

Selling expenses (recovery)

5

 

8

 

(38)

 

(1)

 

2

 

n/m

General and administrative expenses

106

 

126

 

(16)

 

392

 

405

 

(3)

Share-based compensation expense

44

 

20

 

120

 

163

 

37

 

341

Foreign exchange (gain) loss, net of related derivatives

(9)

 

1

 

n/m

 

9

 

360

 

(98)

Gain on sale of investment in Profertil 3

(301)

 

 

 

(301)

 

 

Other expenses

111

 

105

 

6

 

207

 

379

 

(45)

Adjusted EBITDA 2

(133)

 

(160)

 

(17)

 

(427)

 

(452)

 

(6)

Eliminations

 

 

 

 

 

 

 

 

 

 

 

Gross margin

28

 

22

 

27

 

(46)

 

(2)

 

n/m

Adjusted EBITDA 2

26

 

27

 

(4)

 

(46)

 

(1)

 

n/m

1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

2 See Note 2 to the interim financial statements.

3 See Note 6 to the interim financial statements.

 
  • Share-based compensation expense was higher in the fourth quarter and full year of 2025 due to an increase in the fair value of our share-based awards. The fair value of our share-based awards takes into consideration several factors, such as our share price movement, our performance relative to our peer group and our return on invested capital.
  • Foreign exchange (gain) loss, net of related derivatives was lower in the full year of 2025 due to a lower loss on foreign currency derivatives in Brazil and lower foreign exchange losses primarily from our South American Retail region.
  • Gain on sale of investment was higher in the fourth quarter and full year of 2025 due to the sale of our 50 percent equity ownership in Profertil.
  • Other expenses was lower in the full year of 2025 as the comparable period of 2024 included a higher expense for asset retirement obligations related to our non-operating sites.



Finance Costs, Income Taxes and Other Comprehensive (Loss) Income

 

Three Months Ended December 31

 

Twelve Months Ended December 31

($ millions, except as otherwise noted)

2025

 

2024

 

% Change

 

2025

 

2024

 

% Change

Finance costs

183

 

195

 

(6)

 

687

 

720

 

(5)

Income taxes

 

 

 

 

 

 

 

 

 

 

 

Income tax expense

158

 

84

 

88

 

752

 

436

 

72

Actual effective tax rate including discrete items (%)

22

 

42

 

(48)

 

25

 

38

 

(34)

Other comprehensive income (loss)

33

 

(298)

 

n/m

 

224

 

(234)

 

n/m

  • Income tax expense increased in the fourth quarter and full year of 2025 mainly due to higher earnings. The decrease in the actual effective tax rate for the three months ended December 31, 2025 is mainly due to the tax impact of the gain on sale of investment in Profertil. The decrease in the actual effective tax rate for the full year of 2025 is mainly due to lower non-recognizable losses in South America compared to the same period in 2024.
  • Other comprehensive income (loss) increased in thefourth quarter and full year of 2025 mainly due to the appreciation of the Australian, Brazilian and Canadian currencies, relative to the US dollar, compared to losses for the same periods in 2024.



Forward-Looking Statements

Certain statements and other information included in this document, including within the “Market Outlook and Guidance” section, constitute “forward-looking information” or “forward-looking statements” (collectively, “forward-looking statements”) under applicable securities laws (such statements are often accompanied by words such as “anticipate”, “forecast”, “expect”, “believe”, “may”, “will”, “should”, “estimate”, “project”, “intend” or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to: Nutrien's business strategies, plans, prospects and opportunities; Nutrien's 2026 full-year guidance, including expectations regarding Retail adjusted EBITDA, Potash sales volumes, Nitrogen sales volumes, Phosphate sales volumes, depreciation and amortization, finance costs, effective tax rate on adjusted net earnings and capital expenditures, including the assumptions and expectations stated therein; expectations regarding our capital allocation intentions and strategies including our intentions with respect to our strategic actions, including the review of strategic alternatives for our Phosphate business and the controlled shutdown of our Trinidad Nitrogen facility and options for our Trinidad operations and expectations related thereto, including the expected timing for strategic decisions in respect thereof; our expectations regarding Nutrien's strategic priorities and our ability to advance and achieve such strategic priorities in 2026 and beyond; expectations regarding various performance targets in 2026 and beyond and our ability to achieve those; capital spending expectations for 2026 and beyond; expectations regarding performance of our operating segments in 2026 and beyond; the expectation that internally generated cash flow, supplemented by available borrowings, if necessary, will be sufficient to meet our anticipated capital expenditures, planned growth and development activities, and other cash requirements; expectations regarding payment of dividends and share repurchases; our operating segment market outlooks and our expectations for market conditions and fundamentals, and the anticipated supply and demand for our products and services, including the expected impact of supply availability on global shipments of phosphate fertilizer and the expected impact of affordability on demand, crop input demand, expected market, industry and growing conditions with respect to crop nutrient application rates, planted acres, farmer crop investment, crop mix, including the need to replenish soil nutrient levels, input costs, production volumes and expenses, shipments, natural gas costs and availability, consumption, prices, operating rates and the impact of seasonality, import and export volumes, tariffs, trade or export restrictions, economic sanctions and restrictions, operating rates, inventories, crop development and natural gas curtailments; the negotiation of sales contracts; expected grower margins; acquisitions and divestitures and the anticipated benefits thereof; and expectations in connection with our ability to generate free cash flow and deliver long-term returns to shareholders.

These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty.

The additional key assumptions that have been made in relation to the operation of our business as currently planned and our ability to achieve our business objectives include, among other things, assumptions with respect to: our ability to successfully implement our business strategies, growth and capital allocation investments and initiatives that we will conduct our operations and achieve results of operations as anticipated; growth in crop nutrient sales volumes; our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures, and that we will be able to implement our standards, controls, procedures and policies in respect of any acquired businesses and realize the expected synergies on the anticipated timeline or at all; increased proprietary products gross margin; successful execution of margin improvement plan in Brazil; a return to historical average crop protection product margin percentages; continued reliability improvements; sustained operating rates in Phosphate and Nitrogen; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, expenses, margins, demand, supply, product availability, shipments, consumption, weather conditions, supplier agreements, product distribution agreements, inventory levels, exports, tariffs, including general or retaliatory tariffs, trade restrictions, international trade arrangements, government support, crop development and cost of labor and interest, exchange and effective tax rates; potash demand growth in offshore markets; global economic conditions and the accuracy of our market outlook expectations for 2026 and in the future; assumptions related to our assessment of recoverable amount estimates of our assets; our intention to complete share repurchases under our normal course issuer bid programs, the funding of such share repurchases, existing and future market conditions, including with respect to the price of our common shares, capital allocation priorities and compliance with respect to applicable limitations under securities laws and regulations and stock exchange policies and assumptions related to our ability to fund our dividends at the current level; our expectations regarding the impacts, direct and indirect, of certain geopolitical conflicts on, among other things, global supply and demand, including for crop nutrients, energy and commodity prices, global interest rates, supply chains and the global macroeconomic environment, including inflation; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; availability of investment opportunities that align with our strategic priorities and growth strategy; our ability to maintain investment grade ratings and achieve our performance targets; and our ability to successfully negotiate sales and other contracts and our ability to successfully implement new initiatives and programs.

Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: general global economic, market and business conditions; failure to achieve expected results of our business strategy, capital allocation initiatives, results of operations or targets; failure to complete announced and future strategic and asset optimization initiatives, acquisitions or divestitures at all or on the expected terms and within the expected timeline; seasonality of our business; climate change and weather conditions, including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including general or retaliatory tariffs, trade restrictions, or other changes to international trade arrangements; the results of our review of strategic alternative for our Phosphate business, including the process and the timing thereof, and whether the review will result in Nutrien undertaking a transaction, including the terms and timing relating thereto, the completion thereof and realizing benefits resulting therefrom; the effects of current and future multinational trade agreements or other developments affecting the level of trade or export restrictions and climate change initiatives), government ownership requirements, changes in environmental, tax, antitrust and other laws or regulations and the interpretation thereof; political or military risks, including civil unrest, actions by armed groups or conflict and malicious acts including terrorism and industrial espionage; our ability to access sufficient, cost-effective and timely transportation, distribution and storage of products (including potential rail transportation and port disruptions due to labor strikes and/or work stoppages or other similar actions); the occurrence of a major environmental or safety incident or becoming subject to legal or regulatory proceedings; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities or challenges related to our major facilities that are out of our control; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; the risk that rising interest rates and/or deteriorated business operating results may result in the further impairment of assets or goodwill attributed to certain of our cash generating units; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; geopolitical conflicts and their potential impact on, among other things, global market conditions and supply and demand, including for crop nutrients, energy and commodity prices, interest rates, supply chains and the global economy generally; our ability to execute on our strategies related to environmental, social and governance matters, and achieve related expectations, targets and commitments, including risks associated with disclosure thereof; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the SEC.

The purpose of our Retail adjusted EBITDA, depreciation and amortization, finance costs, effective tax rate and capital expenditures guidance ranges are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.



Terms and Definitions

For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the “Terms and definitions” section of our 2024 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, “n/m” indicates information that is not meaningful, and all financial amounts are stated in millions of US dollars, unless otherwise noted.



About Nutrien

Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve farmers. Our vision is to be the leading global agricultural solutions provider, delivering superior shareholder value through safe and sustainable operations. To achieve this vision, our strategy is anchored in three priorities: simplify and focus, operational excellence and a disciplined and intentional approach to capital allocation. This strategy is designed to create low-risk, structural free cash flow growth by leveraging our core competencies and to deliver reliable, growing cash returns to shareholders.

More information about Nutrien can be found at www.nutrien.com.

Selected financial data for download can be found in our data tool at https://www.nutrien.com/investors/interactive-data-tool

Such data is not incorporated by reference herein.

Nutrien will host a Conference Call on Thursday, February 19, 2026 at 10:00 a.m. Eastern Time.

Telephone conference dial-in numbers:

  • From Canada and the US: 1-800-990-2777
  • International: 1-416-855-9085
  • Conference ID: 93473. Please dial in 15 minutes prior to ensure you are placed on the call in a timely manner.

Live Audio Webcast: Visit https://www.nutrien.com/news/events/2025-q4-earnings-conference-call



Non-GAAP Financial Measures

We use both IFRS measures and certain non-GAAP financial measures to assess performance. Non-GAAP financial measures are financial measures disclosed by the Company that: (a) depict historical or expected future financial performance, financial position or cash flow of the Company; (b) with respect to their composition, exclude amounts that are included in, or include amounts that are excluded from, the composition of the most directly comparable financial measure disclosed in the primary financial statements of the Company; (c) are not disclosed in the financial statements of the Company; and (d) are not a ratio, fraction, percentage or similar representation. Non-GAAP ratios are financial measures disclosed by the Company that are in the form of a ratio, fraction, percentage or similar representation that has a non-GAAP financial measure as one or more of its components, and that are not disclosed in the financial statements of the Company.

These non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under IFRS and, therefore, are unlikely to be comparable to similar financial measures presented by other companies. Management believes these non-GAAP financial measures and non-GAAP ratios provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-GAAP financial measures and non-GAAP ratios should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

The following section outlines our non-GAAP financial measures and non-GAAP ratios, their compositions, and why management uses each measure. It also includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-GAAP financial measures and non-GAAP ratios are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As additional non-recurring or unusual items arise in the future, we generally exclude these items in our calculations.

Adjusted EBITDA (Consolidated)

Most directly comparable IFRS financial measure: Net earnings (loss).

Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, share-based compensation and foreign exchange gain/loss (net of related derivatives). We also adjust this measure for the following other income and expenses that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on sale of certain businesses and investments, asset retirement obligations (“ARO”) and accrued environmental costs (“ERL”) related to our non-operating sites, and loss related to financial instruments in Argentina.

Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations and as a component of employee remuneration calculations.

 

Three Months Ended
December 31

 

Twelve Months Ended
December 31

($ millions)

2025

 

2024

 

2025

 

2024

Net earnings

580

 

118

 

2,297

 

700

Finance costs

183

 

195

 

687

 

720

Income tax expense

158

 

84

 

752

 

436

Depreciation and amortization

567

 

590

 

2,369

 

2,339

EBITDA 1

1,488

 

987

 

6,105

 

4,195

Adjustments:

 

 

 

 

 

 

 

Share-based compensation expense

44

 

20

 

163

 

37

Foreign exchange (gain) loss, net of related derivatives

(9)

 

1

 

9

 

360

ARO/ERL related expenses (income) for non-operating sites

9

 

(1)

 

2

 

151

Loss related to financial instruments in Argentina

 

1

 

 

35

Restructuring costs

46

 

47

 

68

 

47

Impairment of assets

 

 

 

530

Gain on sale of investment in Profertil

(301)

 

 

(301)

 

Adjusted EBITDA

1,277

 

1,055

 

6,046

 

5,355

1 EBITDA is calculated as net earnings before finance costs, income taxes, and depreciation and amortization.

 
 

Adjusted Net Earnings and Adjusted Net Earnings Per Share

Most directly comparable IFRS financial measure: Net earnings (loss) and diluted net earnings (loss) per share.

Definition: Adjusted net earnings and related per share information are calculated as net earnings (loss) before share-based compensation and foreign exchange gain/loss (net of related derivatives), net of tax. We also adjust this measure for the following other income and expenses (net of tax) that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on sale of certain businesses and investments, gain or loss on early extinguishment of debt or on settlement of derivatives due to discontinuance of hedge accounting, asset retirement obligations and accrued environmental costs related to our non-operating sites, loss related to financial instruments in Argentina, change in recognition of tax losses and deductible temporary differences related to impairments and certain changes to tax declarations. We generally apply the annual forecasted effective tax rate to specific adjustments during the year, and at year-end, we apply the actual effective tax rate.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations and is used as a component of employee remuneration calculations.

 

Three Months Ended

December 31, 2025

 

Twelve Months Ended

December 31, 2025

 

 

 

 

 

Per

 

 

 

 

 

Per

 

Increases

 

 

 

Diluted

 

Increases

 

 

 

Diluted

($ millions, except as otherwise noted)

(Decreases)

 

Post-Tax

 

Share

 

(Decreases)

 

Post-Tax

 

Share

Net earnings attributable to equity holders of Nutrien

 

 

571

 

1.18

 

 

 

2,267

 

4.66

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

Share-based compensation expense

44

 

33

 

0.07

 

163

 

123

 

0.25

Foreign exchange (gain) loss, net of related derivatives

(9)

 

(8)

 

(0.02)

 

9

 

6

 

0.03

Restructuring costs

46

 

41

 

0.09

 

68

 

59

 

0.12

ARO/ERL related expenses for non-operating sites

9

 

7

 

0.01

 

2

 

2

 

Gain on sale of investment in Profertil

(301)

 

(241)

 

(0.50)

 

(301)

 

(241)

 

(0.50)

Sub-total adjustments

(211)

 

(168)

 

(0.35)

 

(59)

 

(51)

 

(0.10)

Adjusted net earnings

 

 

403

 

0.83

 

 

 

2,216

 

4.56

 

 

Three Months Ended

December 31, 2024

 

Twelve Months Ended

December 31, 2024

 

 

 

 

 

Per

 

 

 

 

 

Per

 

Increases

 

 

 

Diluted

 

Increases

 

 

 

Diluted

($ millions, except as otherwise noted)

(Decreases)

 

Post-Tax

 

Share

 

(Decreases)

 

Post-Tax

 

Share

Net earnings attributable to equity holders of Nutrien

 

 

113

 

0.23

 

 

 

674

 

1.36

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

Share-based compensation expense

20

 

15

 

0.03

 

37

 

27

 

0.05

Foreign exchange loss (gain), net of related derivatives

1

 

(16)

 

(0.03)

 

360

 

346

 

0.70

Restructuring costs

47

 

38

 

0.08

 

47

 

38

 

0.08

Impairment of assets

 

 

 

530

 

492

 

1.00

ARO/ERL related (income) expenses for non-operating sites

(1)

 

(1)

 

 

151

 

106

 

0.21

Loss related to financial instruments in Argentina

1

 

1

 

 

35

 

35

 

0.07

Sub-total adjustments

68

 

37

 

0.08

 

1,160

 

1,044

 

2.11

Adjusted net earnings

 

 

150

 

0.31

 

 

 

1,718

 

3.47

 
 

Effective Tax Rate on Adjusted Net Earnings

Effective tax rate on adjusted net earnings guidance is a forward-looking non-GAAP financial measure as it includes adjusted net earnings, which is a non-GAAP financial measure. It is provided to assist readers in understanding our expected financial results. Effective tax rate on adjusted net earnings guidance excludes certain items that management is aware of that permit management to focus on the performance of our operations (see the Adjusted Net Earnings and Adjusted Net Earnings Per Share section for items generally adjusted). We do not provide a reconciliation of this forward-looking measure to the most directly comparable financial measures calculated and presented in accordance with IFRS because a meaningful or accurate calculation of reconciling items and the information is not available without unreasonable effort due to unknown variables, including the timing and amount of certain reconciling items, and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. The probable significance of such unavailable information, which could be material to future results, cannot be addressed.

Effective tax rate on adjusted net earnings is calculated as adjusted income tax expense divided by adjusted earnings before income taxes. We use this measure to provide the actual result for a previously disclosed forward-looking effective tax rate on adjusted net earnings guidance.

($ millions, except as otherwise noted)

 

2025

Earnings before income taxes

 

3,049

Adjustments 1

 

(59)

Adjusted earnings before income taxes

 

2,990

 

 

 

Income tax expense

 

752

Adjustments 2

 

(8)

Adjusted income tax expense

 

744

 

 

 

Effective tax rate on adjusted net earnings (%)

 

24.9

1 Calculated as sum of pre-tax adjustments noted in the Adjusted Net Earnings section.

2 Calculated as difference between the sum of pre-tax and post-tax adjustments noted in the Adjusted Net Earnings section.

 

Gross Margin Excluding Depreciation and Amortization Per Tonne – Manufactured Product

Most directly comparable IFRS financial measure: Gross margin.

Definition: Gross margin per tonne less depreciation and amortization per tonne for manufactured products. Reconciliations are provided in the “Segment Results” section.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

Potash Controllable Cash Cost of Product Manufactured (“COPM”) Per Tonne

Most directly comparable IFRS financial measure: Cost of goods sold (“COGS”) for the Potash segment.

Definition: Total Potash COGS excluding depreciation and amortization expense included in COPM, royalties, natural gas costs and carbon taxes, change in inventory, and other adjustments, divided by potash production tonnes.

Why we use the measure and why it is useful to investors: To assess operational performance. Potash controllable cash COPM excludes the effects of production from other periods and the impacts of our long-term investment decisions, supporting a focus on the performance of our day-to-day operations. Potash controllable cash COPM also excludes royalties and natural gas costs and carbon taxes, which management does not consider controllable, as they are primarily driven by regulatory and market conditions.

 

Three Months Ended
December 31

 

Twelve Months Ended
December 31

($ millions, except as otherwise noted)

2025

 

2024

 

2025

 

2024

Total COGS – Potash

324

 

309

 

1,581

 

1,448

Change in inventory

94

 

66

 

(2)

 

36

Other adjustments 1

(7)

 

(7)

 

(27)

 

(21)

COPM

411

 

368

 

1,552

 

1,463

Depreciation and amortization in COPM

(157)

 

(142)

 

(606)

 

(581)

Royalties in COPM

(25)

 

(17)

 

(93)

 

(79)

Natural gas costs and carbon taxes in COPM

(12)

 

(9)

 

(42)

 

(36)

Controllable cash COPM

217

 

200

 

811

 

767

Production volumes (tonnes – thousands)

3,539

 

3,369

 

13,966

 

14,205

Potash controllable cash COPM per tonne

61

 

59

 

58

 

54

1 Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

 

Nutrien Financial Adjusted Net Interest Margin

Definition: Nutrien Financial revenue less deemed interest expense divided by average Nutrien Financial net receivables outstanding for the last four rolling quarters.

Why we use the measure and why it is useful to investors: Used by credit rating agencies and others to evaluate the financial performance of Nutrien Financial.

 

Rolling Four Quarters Ended December 31, 2025

($ millions, except as otherwise noted)

Q1 2025

 

Q2 2025

 

Q3 2025

 

Q4 2025

 

Total/Average

Nutrien Financial revenue

70

 

135

 

89

 

82

 

 

Deemed interest expense 1

(29)

 

(49)

 

(52)

 

(47)

 

 

Net interest

41

 

86

 

37

 

35

 

199

 

 

 

 

 

 

 

 

 

 

Average Nutrien Financial net receivables

2,569

 

4,645

 

4,452

 

3,106

 

3,693

Nutrien Financial adjusted net interest margin (%)

 

 

 

 

 

 

 

 

5.4

 

 

 

 

 

 

 

 

 

 

 

Rolling Four Quarters Ended December 31, 2024

($ millions, except as otherwise noted)

Q1 2024

 

Q2 2024

 

Q3 2024

 

Q4 2024

 

Total/Average

Nutrien Financial revenue

66

 

133

 

85

 

77

 

 

Deemed interest expense 1

(27)

 

(50)

 

(52)

 

(45)

 

 

Net interest

39

 

83

 

33

 

32

 

187

 

 

 

 

 

 

 

 

 

 

Average Nutrien Financial net receivables

2,489

 

4,560

 

4,318

 

2,877

 

3,561

Nutrien Financial adjusted net interest margin (%)

 

 

 

 

 

 

 

 

5.3

1 Average borrowing rate applied to the notional debt required to fund the portfolio of receivables from customers monitored and serviced by Nutrien Financial.

 

Retail Cash Operating Coverage Ratio

Definition: Retail selling, general and administrative, and other expenses (income), excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate cash flow.

 

Rolling Four Quarters Ended December 31, 2025

($ millions, except as otherwise noted)

Q1 2025

 

Q2 2025

 

Q3 2025

 

Q4 2025

 

Total

Selling expenses

755

 

948

 

792

 

811

 

3,306

General and administrative expenses

44

 

44

 

44

 

40

 

172

Other (income) expenses

25

 

54

 

40

 

4

 

123

Operating expenses

824

 

1,046

 

876

 

855

 

3,601

Depreciation and amortization in operating expenses

(179)

 

(172)

 

(179)

 

(184)

 

(714)

Operating expenses excluding depreciation and amortization

645

 

874

 

697

 

671

 

2,887

 

 

 

 

 

 

 

 

 

 

Gross margin

686

 

2,018

 

922

 

977

 

4,603

Depreciation and amortization in cost of goods sold

5

 

5

 

5

 

5

 

20

Gross margin excluding depreciation and amortization

691

 

2,023

 

927

 

982

 

4,623

Cash operating coverage ratio (%)

 

 

 

 

 

 

 

 

62

 

 

 

 

 

 

 

 

 

 

 

Rolling Four Quarters Ended December 31, 2024

($ millions, except as otherwise noted)

Q1 2024

 

Q2 2024

 

Q3 2024

 

Q4 2024

 

Total

Selling expenses

790

 

1,005

 

815

 

808

 

3,418

General and administrative expenses

52

 

51

 

51

 

37

 

191

Other expenses (income)

22

 

41

 

32

 

(8)

 

87

Operating expenses

864

 

1,097

 

898

 

837

 

3,696

Depreciation and amortization in operating expenses

(190)

 

(193)

 

(182)

 

(186)

 

(751)

Operating expenses excluding depreciation and amortization

674

 

904

 

716

 

651

 

2,945

 

 

 

 

 

 

 

 

 

 

Gross margin

747

 

2,029

 

859

 

986

 

4,621

Depreciation and amortization in cost of goods sold

4

 

3

 

8

 

5

 

20

Gross margin excluding depreciation and amortization

751

 

2,032

 

867

 

991

 

4,641

Cash operating coverage ratio (%)

 

 

 

 

 

 

 

 

63

 

Retail Average Working Capital to Sales and Retail Average Working Capital to Sales Excluding Nutrien Financial

Definition: Retail average working capital divided by Retail sales for the last four rolling quarters. We also look at this metric excluding Nutrien Financial revenue and working capital.

Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively. The metric excluding Nutrien Financial shows the impact that the working capital of Nutrien Financial has on the ratio.

 

Rolling Four Quarters Ended December 31, 2025

($ millions, except as otherwise noted)

Q1 2025

 

Q2 2025

 

Q3 2025

 

Q4 2025

 

Average/Total

Current assets

11,510

 

11,442

 

10,823

 

11,185

 

 

Current liabilities

(7,561)

 

(8,051)

 

(5,348)

 

(8,275)

 

 

Working capital

3,949

 

3,391

 

5,475

 

2,910

 

3,931

Nutrien Financial working capital

(2,569)

 

(4,645)

 

(4,452)

 

(3,106)

 

 

Working capital excluding Nutrien Financial

1,380

 

(1,254)

 

1,023

 

(196)

 

238

 

 

 

 

 

 

 

 

 

 

Sales

3,090

 

7,959

 

3,427

 

3,144

 

17,620

Nutrien Financial revenue

(70)

 

(135)

 

(89)

 

(82)

 

 

Sales excluding Nutrien Financial

3,020

 

7,824

 

3,338

 

3,062

 

17,244

 

 

 

 

 

 

 

 

 

 

Average working capital to sales (%)

 

 

 

 

 

 

 

 

22

Average working capital to sales excluding Nutrien Financial (%)

 

 

 

1

 

 

 

 

 

 

 

 

 

 

 

Rolling Four Quarters Ended December 31, 2024

($ millions, except as otherwise noted)

Q1 2024

 

Q2 2024

 

Q3 2024

 

Q4 2024

 

Average/Total

Current assets

11,821

 

11,181

 

10,559

 

10,360

 

 

Current liabilities

(8,401)

 

(8,002)

 

(5,263)

 

(8,028)

 

 

Working capital

3,420

 

3,179

 

5,296

 

2,332

 

3,557

Nutrien Financial working capital

(2,489)

 

(4,560)

 

(4,318)

 

(2,877)

 

 

Working capital excluding Nutrien Financial

931

 

(1,381)

 

978

 

(545)

 

(4)

 

 

 

 

 

 

 

 

 

 

Sales

3,308

 

8,074

 

3,271

 

3,179

 

17,832

Nutrien Financial revenue

(66)

 

(133)

 

(85)

 

(77)

 

 

Sales excluding Nutrien Financial

3,242

 

7,941

 

3,186

 

3,102

 

17,471

 

 

 

 

 

 

 

 

 

 

Average working capital to sales (%)

 

 

 

 

 

 

 

 

20

Average working capital to sales excluding Nutrien Financial (%)

 

 

 

 
 

Other Financial Measures

Selected Additional Financial Data

Nutrien Financial

As at December 31, 2025

As at

December 31, 2024

($ millions)

Current

<31 Days
past due

31–90 Days
past due

>90 Days
past due

Gross receivables

Allowance 1

Net
receivables 2

Net

receivables

North America

1,831

260

110

181

2,382

(50)

2,332

2,178

International

647

82

21

31

781

(7)

774

699

Nutrien Financial

receivables

2,478

342

131

212

3,163

(57)

3,106

2,877

1 Bad debt expense on the above receivables for the twelve months ended December 31, 2025 was $46 million, in the Retail segment.

2 In 2025, we assume a debt-to-equity ratio of 9:1 (2024 – 7:1) in funding Nutrien Financial receivables, based on the underlying credit quality of the assets.

 
 

Supplementary Financial Measures

Supplementary financial measures are financial measures disclosed by the Company that (a) are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company, (b) are not disclosed in the financial statements of the Company, (c) are not non-GAAP financial measures, and (d) are not non-GAAP ratios.

The following section provides an explanation of the composition of those supplementary financial measures, if not previously provided.

Sustaining capital expenditures: Represents capital expenditures that are required to sustain operations at existing levels and include major repairs and maintenance and plant turnarounds.

Investing capital expenditures: Represents capital expenditures related to significant expansions of current operations or to create cost savings (synergies). Investing capital expenditures exclude capital outlays for business acquisitions and equity-accounted investees.

Mine development and pre-stripping capital expenditures: Represents capital expenditures that are required for activities to open new areas underground and/or develop a mine or ore body to allow for future production mining and activities required to prepare and/or access the ore, i.e., removal of an overburden that allows access to the ore.

Cash used for dividends and share repurchases: Calculated as dividends paid to Nutrien’s shareholders plus repurchase of common shares as reflected in the unaudited condensed consolidated statements of cash flows. This measure is useful as it represents return of cash to shareholders.



Condensed Consolidated Financial Statements

Unaudited
Condensed Consolidated Statements of Earnings

 

 

Three Months Ended

 

Twelve Months Ended

 

 

December 31

 

December 31

($ millions, except as otherwise noted)

Note

2025

 

2024

 

2025

 

2024

Sales

2, 10

5,340

 

5,079

 

26,885

 

25,972

Freight, transportation and distribution

 

198

 

215

 

936

 

956

Cost of goods sold

 

3,254

 

3,283

 

17,602

 

17,486

Gross Margin

 

1,888

 

1,581

 

8,347

 

7,530

Selling expenses

 

817

 

813

 

3,320

 

3,435

General and administrative expenses

 

156

 

176

 

600

 

644

Provincial mining taxes

 

83

 

45

 

372

 

255

Share-based compensation expense

 

44

 

20

 

163

 

37

Impairment of assets

3

 

 

 

530

Foreign exchange (gain) loss, net of related derivatives

7

(9)

 

1

 

9

 

360

Gain on sale of investment in Profertil

6

(301)

 

 

(301)

 

Other expenses

4

177

 

129

 

448

 

413

Earnings Before Finance Costs and Income Taxes

921

 

397

 

3,736

 

1,856

Finance costs

 

183

 

195

 

687

 

720

Earnings Before Income Taxes

 

738

 

202

 

3,049

 

1,136

Income tax expense

5

158

 

84

 

752

 

436

Net Earnings

 

580

 

118

 

2,297

 

700

Attributable to

 

 

 

 

 

 

 

 

Equity holders of Nutrien

 

571

 

113

 

2,267

 

674

Non-controlling interest

 

9

 

5

 

30

 

26

Net Earnings

 

580

 

118

 

2,297

 

700

 

 

 

 

 

 

 

 

 

Net Earnings Per Share Attributable to Equity Holders of Nutrien ("EPS")

Basic

 

1.18

 

0.23

 

4.66

 

1.36

Diluted

 

1.18

 

0.23

 

4.66

 

1.36

Weighted average shares outstanding for basic EPS

 

483,028,000

 

492,843,000

 

486,335,000

 

494,198,000

Weighted average shares outstanding for diluted EPS

 

483,234,000

 

492,930,000

 

486,518,000

 

494,365,000

 

 

 

 

 

 

 

 

 

(See Notes to the Condensed Consolidated Financial Statements)

 

Condensed Consolidated Statements of Comprehensive Income (Loss)

 

Three Months Ended

 

Twelve Months Ended

 

December 31

 

December 31

($ millions, net of related income taxes)

2025

 

2024

 

2025

 

2024

Net Earnings

580

 

118

 

2,297

 

700

Other comprehensive income (loss)

 

 

 

 

 

 

 

Items that will not be reclassified to net earnings:

 

 

 

 

 

 

 

Net actuarial gain on defined benefit plans

6

 

17

 

6

 

17

Net fair value gain (loss) on investments

 

2

 

(18)

 

55

Items that have been or may be subsequently reclassified to net earnings:

 

 

 

 

 

 

 

Gain (loss) on currency translation of foreign operations

16

 

(282)

 

212

 

(254)

Other

11

 

(35)

 

24

 

(52)

Other Comprehensive Income (Loss)

33

 

(298)

 

224

 

(234)

Comprehensive Income (Loss)

613

 

(180)

 

2,521

 

466

Attributable to

 

 

 

 

 

 

 

Equity holders of Nutrien

604

 

(182)

 

2,490

 

443

Non-controlling interest

9

 

2

 

31

 

23

Comprehensive Income (Loss)

613

 

(180)

 

2,521

 

466

 

 

 

 

 

 

 

 

(See Notes to the Condensed Consolidated Financial Statements)

 

Condensed Consolidated Statements of Cash Flows

 

 

Three Months Ended

 

Twelve Months Ended

 

 

December 31

 

December 31

($ millions)

Note

2025

 

2024

 

2025

 

2024

Operating Activities

 

 

 

 

 

 

 

 

Net earnings

 

580

 

118

 

2,297

 

700

Adjustments for:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

567

 

590

 

2,369

 

2,339

Share-based compensation expense

 

44

 

20

 

163

 

37

Impairment of assets

3

 

 

 

530

Gain on sale of investment in Profertil

6

(301)

 

 

(301)

 

Provision for deferred income tax

 

23

 

16

 

250

 

31

Net (undistributed) distributed earnings of equity-accounted investees

 

(1)

 

(22)

 

65

 

(8)

Loss related to financial instruments in Argentina

4

 

1

 

 

35

Long-term income tax receivables and payables

 

(83)

 

30

 

(65)

 

47

Other long-term assets, liabilities and miscellaneous

 

61

 

(16)

 

12

 

311

Cash from operations before working capital changes

 

890

 

737

 

4,790

 

4,022

Changes in non-cash operating working capital:

 

 

 

 

 

 

 

 

Receivables

 

2,120

 

2,170

 

(128)

 

(224)

Inventories and prepaid expenses and other current assets

 

(2,434)

 

(2,205)

 

(557)

 

60

Trade, other payables and accrued liabilities

 

2,401

 

2,421

 

(98)

 

(323)

Cash Provided by Operating Activities

 

2,977

 

3,123

 

4,007

 

3,535

Investing Activities

 

 

 

 

 

 

 

 

Capital expenditures 1

 

(751)

 

(767)

 

(2,005)

 

(2,154)

Business acquisitions, net of cash acquired

 

(11)

 

(15)

 

(23)

 

(21)

Proceeds from (purchase of) investments, held within three months, net

 

35

 

74

 

(33)

 

44

Purchase of investments

 

(1)

 

 

(94)

 

(112)

Proceeds from sale of investments

6

416

 

79

 

838

 

138

Net changes in non-cash working capital

 

61

 

82

 

6

 

27

Other

 

 

28

 

(61)

 

(55)

Cash Used in Investing Activities

 

(251)

 

(519)

 

(1,372)

 

(2,133)

Financing Activities

 

 

 

 

 

 

 

 

Repayment of debt, maturing within three months, net

 

(1,621)

 

(1,231)

 

(696)

 

(142)

Proceeds from debt

8

 

24

 

998

 

1,022

Repayment of debt

8

(527)

 

(527)

 

(1,089)

 

(659)

Repayment of principal portion of lease liabilities

 

(106)

 

(102)

 

(419)

 

(402)

Dividends paid to Nutrien's shareholders

9

(263)

 

(265)

 

(1,061)

 

(1,060)

Repurchase of common shares

9

(150)

 

(134)

 

(551)

 

(184)

Issuance of common shares

 

9

 

2

 

38

 

18

Other

 

(3)

 

(6)

 

(37)

 

(46)

Cash Used in Financing Activities

 

(2,661)

 

(2,239)

 

(2,817)

 

(1,453)

Effect of Exchange Rate Changes on Cash and Cash Equivalents

 

12

 

(32)

 

30

 

(37)

Increase (Decrease) in Cash and Cash Equivalents

 

77

 

333

 

(152)

 

(88)

Cash and Cash Equivalents – Beginning of Period

 

624

 

520

 

853

 

941

Cash and Cash Equivalents – End of Period

 

701

 

853

 

701

 

853

Cash and cash equivalents is composed of:

 

 

 

 

 

 

 

 

Cash

 

566

 

741

 

566

 

741

Short-term investments

 

135

 

112

 

135

 

112

 

 

701

 

853

 

701

 

853

Supplemental Cash Flows Information

 

 

 

 

 

 

 

 

Interest paid

 

220

 

244

 

738

 

740

Income taxes paid

 

134

 

61

 

335

 

321

Total cash outflow for leases

 

144

 

140

 

567

 

558

1 Includes additions to property, plant and equipment, and intangible assets for the three months ended December 31, 2025 of $707 million and $44 million (2024 – $735 million and $32 million), respectively, and for the twelve months ended December 31, 2025 of $1,882 million and $123 million (2024 – $2,025 million and $129 million), respectively.

 

(See Notes to the Condensed Consolidated Financial Statements)

 
 

Condensed Consolidated Statements of Changes in Shareholders’ Equity

 

 

 

 

 

 

 

Accumulated other comprehensive

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(loss) income ("AOCI")

 

 

 

 

 

 

 

($ millions, inclusive of related tax, except as otherwise noted)

Number of
common
shares

 

Share
capital

 

Contributed
surplus

 

(Loss) gain
on currency
translation
of foreign
operations

 

Other

 

Total
AOCI

 

Retained
earnings

 

Equity
holders
of
Nutrien

 

Non-
controlling
interest

 

Total
equity

Balance – December 31, 2023

494,551,730

 

13,838

 

83

 

(286)

 

(10)

 

(296)

 

11,531

 

25,156

 

45

 

25,201

Net earnings

 

 

 

 

 

 

674

 

674

 

26

 

700

Other comprehensive (loss) income

 

 

 

(251)

 

20

 

(231)

 

 

(231)

 

(3)

 

(234)

Shares repurchased for cancellation (Note 9)

(3,944,903)

 

(110)

 

(20)

 

 

 

 

(60)

 

(190)

 

 

(190)

Dividends declared 1

 

 

 

 

 

 

(1,063)

 

(1,063)

 

 

(1,063)

Non-controlling interest transactions

 

 

 

 

 

 

 

 

(33)

 

(33)

Effect of share-based compensation including issuance of common shares

418,619

 

20

 

5

 

 

 

 

 

25

 

 

25

Transfer of net gain on sale of investment

 

 

 

 

 

 

7

 

7

 

 

7

Transfer of net loss on cash flow hedges

 

 

 

 

29

 

29

 

 

29

 

 

29

Transfer of net actuarial gain on defined benefit plans

 

 

 

 

(17)

 

(17)

 

17

 

 

 

Balance – December 31, 2024

491,025,446

 

13,748

 

68

 

(537)

 

22

 

(515)

 

11,106

 

24,407

 

35

 

24,442

Net earnings

 

 

 

 

 

 

2,267

 

2,267

 

30

 

2,297

Other comprehensive income

 

 

 

211

 

12

 

223

 

 

223

 

1

 

224

Shares repurchased for cancellation (Note 9)

(9,829,408)

 

(275)

 

(10)

 

 

 

 

(275)

 

(560)

 

 

(560)

Dividends declared 1

 

 

 

 

 

 

(1,059)

 

(1,059)

 

 

(1,059)

Non-controlling interest transactions

 

 

 

 

 

 

1

 

1

 

(24)

 

(23)

Effect of share-based compensation including issuance of common shares

766,195

 

46

 

(1)

 

 

 

 

 

45

 

 

45

Transfer of net gain on sale of investment

 

 

 

 

(27)

 

(27)

 

27

 

 

 

Transfer of net gain on cash flow hedges

 

 

 

 

(1)

 

(1)

 

 

(1)

 

 

(1)

Transfer of net actuarial gain on defined benefit plans

 

 

 

 

(6)

 

(6)

 

6

 

 

 

Other

 

 

 

(3)

 

 

(3)

 

3

 

 

 

Balance – December 31, 2025

481,962,233

 

13,519

 

57

 

(329)

 

 

(329)

 

12,076

 

25,323

 

42

 

25,365

1 During the twelve months ended December 31, 2025, we declared dividends of $2.18 per share (2024 - $2.16 per share).

 

(See Notes to the Condensed Consolidated Financial Statements)

 
 

Condensed Consolidated Balance Sheets

 

 

As at

 

As at

 

 

December 31

 

December 31

($ millions)

Note

2025

 

2024

Assets

 

 

 

 

Current assets

 

 

 

 

Cash and cash equivalents

 

701

 

853

Receivables

10

5,675

 

5,390

Inventories

 

6,977

 

6,148

Prepaid expenses and other current assets

 

1,396

 

1,401

 

 

14,749

 

13,792

Non-current assets

 

 

 

 

Property, plant and equipment

3

22,747

 

22,604

Goodwill

3

12,136

 

12,043

Intangible assets

3

1,667

 

1,819

Investments

6

144

 

698

Other assets

 

858

 

884

Total Assets

 

52,301

 

51,840

Liabilities

 

 

 

 

Current liabilities

 

 

 

 

Short-term debt

 

873

 

1,534

Current portion of long-term debt

8

513

 

1,037

Current portion of lease liabilities

 

346

 

356

Trade, other payables and accrued liabilities

10

9,309

 

9,118

 

 

11,041

 

12,045

Non-current liabilities

 

 

 

 

Long-term debt

8

9,350

 

8,881

Lease liabilities

 

937

 

999

Deferred income tax liabilities

 

3,666

 

3,539

Pension and other post-retirement benefit liabilities

 

221

 

227

Asset retirement obligations and accrued environmental costs

 

1,468

 

1,543

Other non-current liabilities

 

253

 

164

Total Liabilities

 

26,936

 

27,398

Shareholders’ Equity

 

 

 

 

Share capital

9

13,519

 

13,748

Contributed surplus

 

57

 

68

Accumulated other comprehensive loss

 

(329)

 

(515)

Retained earnings

 

12,076

 

11,106

Equity holders of Nutrien

 

25,323

 

24,407

Non-controlling interest

 

42

 

35

Total Shareholders’ Equity

 

25,365

 

24,442

Total Liabilities and Shareholders’ Equity

 

52,301

 

51,840

 

 

 

 

 

(See Notes to the Condensed Consolidated Financial Statements)

Notes to the Condensed Consolidated Financial Statements

As at and for the Three and Twelve Months Ended December 31, 2025

Note 1 Basis of presentation

Nutrien Ltd. (collectively with its subsidiaries, “Nutrien”, “we”, “us”, “our” or “the Company”) is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers.

These unaudited interim condensed consolidated financial statements (“interim financial statements”) are based on International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, “Interim Financial Reporting”. The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2024 annual audited consolidated financial statements. These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2024 annual audited consolidated financial statements. These interim financial statements are presented in millions of US dollars, unless otherwise indicated, which is the functional currency of Nutrien and the majority of its subsidiaries.

Certain immaterial 2024 figures have been reclassified in Note 2 Segment information and Note 4 Other expenses (income).

In management’s opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year.

These interim financial statements were authorized by the Audit Committee of the Board of Directors for issue on February 18, 2026.

Note 2 Segment information

We have four reportable operating segments: Retail, Potash, Nitrogen and Phosphate. Our downstream Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and provides agronomic application services and solutions, including the services offered through Nutrien Financial. Retail also manufactures and distributes proprietary products and provides services directly to farmers through a network of retail locations in North America, South America and Australia. Our upstream Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each segment produces and are supported by midstream activities, which include the global sales, freight, transportation and distribution of our products, which are reported within these segments, respectively. Potash freight, transportation and distribution costs only apply to our North American potash sales volumes. Sales reported under our Corporate and Others segment relates to our non-core businesses. EBITDA presented in the succeeding tables is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

In the fourth quarter of 2025, the Chief Operating Decision Maker (“CODM”) reassessed our product groupings and determined that the performance of our Purchase for Resale business should be evaluated as part of the Corporate and Others segment. It had previously been recorded in our Nitrogen segment. The Purchase for Resale business focuses primarily on sales to international customers. Purchased product that remains in upstream is primarily purchases of inventory to satisfy sales contracts that we cannot fulfill with our manufactured products. The CODM concluded this change was appropriate based on the nature and strategic alignment of purchase for resale activities. Comparative amounts for the Corporate and Others and Nitrogen segments were reclassified. As a result of the reclassification, the Corporate and Others segment reflected the following increases and the Nitrogen segment reflected the corresponding decreases for the three and twelve months ended December 31, 2024.

 

Three Months Ended

Twelve Months Ended

($ millions)

December 31, 2024

December 31, 2024

Sales

33

173

Gross Margin

1

8

EBITDA

1

4

 

 

Three Months Ended December 31, 2025

 

 

Downstream

 

Upstream and Midstream

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

($ millions)

Retail

 

Potash

 

Nitrogen

 

Phosphate

 

and Others

 

Eliminations

 

Consolidated

Sales

– third party

3,137

 

686

 

994

 

478

 

45

 

 

5,340

 

– intersegment

7

 

106

 

246

 

65

 

 

(424)

 

Sales

– total

3,144

 

792

 

1,240

 

543

 

45

 

(424)

 

5,340

Freight, transportation and distribution 1

 

56

 

147

 

60

 

(1)

 

(64)

 

198

Net sales

3,144

 

736

 

1,093

 

483

 

46

 

(360)

 

5,142

Cost of goods sold

2,167

 

324

 

682

 

430

 

39

 

(388)

 

3,254

Gross margin

977

 

412

 

411

 

53

 

7

 

28

 

1,888

Selling expenses (recovery)

811

 

2

 

5

 

1

 

5

 

(7)

 

817

General and administrative expenses

40

 

3

 

4

 

3

 

106

 

 

156

Provincial mining taxes

 

83

 

 

 

 

 

83

Share-based compensation expense

 

 

 

 

44

 

 

44

Foreign exchange gain, net of related derivatives

 

 

 

 

(9)

 

 

(9)

Gain on sale of investment in Profertil

 

 

 

 

(301)

 

 

(301)

Other expenses

4

 

6

 

32

 

15

 

111

 

9

 

177

Earnings before finance costs and income taxes

122

 

318

 

370

 

34

 

51

 

26

 

921

Depreciation and amortization

189

 

127

 

151

 

73

 

27

 

 

567

EBITDA

311

 

445

 

521

 

107

 

78

 

26

 

1,488

Restructuring costs

 

 

 

 

46

 

 

46

Share-based compensation expense

 

 

 

 

44

 

 

44

ARO/ERL related expenses for non-operating sites

 

 

 

 

9

 

 

9

Foreign exchange gain, net of related derivatives

 

 

 

 

(9)

 

 

(9)

Gain on sale of investment in Profertil

 

 

 

 

(301)

 

 

(301)

Adjusted EBITDA

311

 

445

 

521

 

107

 

(133)

 

26

 

1,277

1 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

 

 

Three Months Ended December 31, 2024

 

 

Downstream

 

Upstream and Midstream

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

($ millions)

Retail

 

Potash

Nitrogen1

 

Phosphate

and Others1

 

Eliminations

 

Consolidated

Sales

– third party

3,179

 

522

920

 

403

55

 

 

5,079

 

– intersegment

 

65

223

 

68

 

(356)

 

Sales

– total

3,179

 

587

1,143

 

471

55

 

(356)

 

5,079

Freight, transportation and distribution 2

 

51

162

 

57

1

 

(56)

 

215

Net sales

3,179

 

536

981

 

414

54

 

(300)

 

4,864

Cost of goods sold

2,193

 

309

669

 

394

40

 

(322)

 

3,283

Gross margin

986

 

227

312

 

20

14

 

22

 

1,581

Selling expenses (recovery)

808

 

1

2

 

1

8

 

(7)

 

813

General and administrative expenses

37

 

2

8

 

3

126

 

 

176

Provincial mining taxes

 

45

 

 

 

45

Share-based compensation expense

 

 

20

 

 

20

Foreign exchange loss, net of related derivatives

 

 

1

 

 

1

Other (income) expenses

(8)

 

22

1

 

7

105

 

2

 

129

Earnings (loss) before finance costs and income taxes

149

 

157

301

 

9

(246)

 

27

 

397

Depreciation and amortization

191

 

134

170

 

77

18

 

 

590

EBITDA

340

 

291

471

 

86

(228)

 

27

 

987

Restructuring costs

 

 

47

 

 

47

Share-based compensation expense

 

 

20

 

 

20

Loss related to financial instruments in Argentina

 

 

1

 

 

1

ARO/ERL related income for non-operating sites

 

 

(1)

 

 

(1)

Foreign exchange loss, net of related derivatives

 

 

1

 

 

1

Adjusted EBITDA

340

 

291

471

 

86

(160)

 

27

 

1,055

1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

2 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

 

 

Twelve Months Ended December 31, 2025

 

 

Downstream

 

Upstream and Midstream

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

($ millions)

Retail

 

Potash

 

Nitrogen

 

Phosphate

 

and Others

 

Eliminations

 

Consolidated

Sales

– third party

17,601

 

3,571

 

3,807

 

1,660

 

246

 

 

26,885

 

– intersegment

19

 

424

 

932

 

298

 

 

(1,673)

 

Sales

– total

17,620

 

3,995

 

4,739

 

1,958

 

246

 

(1,673)

 

26,885

Freight, transportation and

distribution 1

 

402

 

552

 

224

 

(1)

 

(241)

 

936

Net sales

17,620

 

3,593

 

4,187

 

1,734

 

247

 

(1,432)

 

25,949

Cost of goods sold

13,017

 

1,581

 

2,580

 

1,590

 

220

 

(1,386)

 

17,602

Gross margin

4,603

 

2,012

 

1,607

 

144

 

27

 

(46)

 

8,347

Selling expenses (recovery)

3,306

 

10

 

26

 

6

 

(1)

 

(27)

 

3,320

General and administrative expenses

172

 

10

 

18

 

8

 

392

 

 

600

Provincial mining taxes

 

372

 

 

 

 

 

372

Share-based compensation expense

 

 

 

 

163

 

 

163

Foreign exchange loss, net of related derivatives

 

 

 

 

9

 

 

9

Gain on sale of investment in Profertil

 

 

 

 

(301)

 

 

(301)

Other expenses

123

 

26

 

32

 

33

 

207

 

27

 

448

Earnings (loss) before finance costs and income taxes

1,002

 

1,594

 

1,531

 

97

 

(442)

 

(46)

 

3,736

Depreciation and amortization

734

 

660

 

616

 

285

 

74

 

 

2,369

EBITDA

1,736

 

2,254

 

2,147

 

382

 

(368)

 

(46)

 

6,105

Restructuring costs

 

 

 

 

68

 

 

68

Share-based compensation expense

 

 

 

 

163

 

 

163

ARO/ERL related expenses for non-operating sites

 

 

 

 

2

 

 

2

Foreign exchange loss, net of related derivatives

 

 

 

 

9

 

 

9

Gain on sale of investment in Profertil

 

 

 

 

(301)

 

 

(301)

Adjusted EBITDA

1,736

 

2,254

 

2,147

 

382

 

(427)

 

(46)

 

6,046

1 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

 

 

Twelve Months Ended December 31, 2024

 

 

Downstream

 

Upstream and Midstream

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

($ millions)

Retail

 

Potash

Nitrogen1

 

Phosphate

and Others1

 

Eliminations

 

Consolidated

Sales

– third party

17,832

 

3,008

3,327

 

1,610

195

 

 

25,972

 

– intersegment

 

370

807

 

278

 

(1,455)

 

Sales

– total

17,832

 

3,378

4,134

 

1,888

195

 

(1,455)

 

25,972

Freight, transportation and

distribution 2

 

389

558

 

231

4

 

(226)

 

956

Net sales

17,832

 

2,989

3,576

 

1,657

191

 

(1,229)

 

25,016

Cost of goods sold

13,211

 

1,448

2,374

 

1,510

170

 

(1,227)

 

17,486

Gross margin

4,621

 

1,541

1,202

 

147

21

 

(2)

 

7,530

Selling expenses (recovery)

3,418

 

10

24

 

6

2

 

(25)

 

3,435

General and administrative expenses

191

 

12

22

 

14

405

 

 

644

Provincial mining taxes

 

255

 

 

 

255

Share-based compensation expense

 

 

37

 

 

37

Impairment of assets

335

 

195

 

 

 

530

Foreign exchange loss, net of related derivatives

 

 

360

 

 

360

Other expenses (income)

87

 

25

(135)

 

33

379

 

24

 

413

Earnings (loss) before finance costs and income taxes

590

 

1,239

1,096

 

94

(1,162)

 

(1)

 

1,856

Depreciation and amortization

771

 

609

589

 

290

80

 

 

2,339

EBITDA

1,361

 

1,848

1,685

 

384

(1,082)

 

(1)

 

4,195

Restructuring costs

 

 

47

 

 

47

Share-based compensation expense

 

 

37

 

 

37

Impairment of assets

335

 

195

 

 

 

530

Loss related to financial instruments in Argentina

 

 

35

 

 

35

ARO/ERL related expenses for non-operating sites

 

 

151

 

 

151

Foreign exchange loss, net of related derivatives

 

 

360

 

 

360

Adjusted EBITDA

1,696

 

1,848

1,880

 

384

(452)

 

(1)

 

5,355

1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

2 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

 

Three Months Ended

 

Twelve Months Ended

 

December 31

 

December 31

($ millions)

2025

 

2024

 

2025

 

2024

Retail sales by product line

 

 

 

 

 

 

 

Crop nutrients

1,512

 

1,528

 

7,285

 

7,211

Crop protection products

931

 

948

 

6,105

 

6,313

Seed

162

 

184

 

2,128

 

2,235

Services and other

254

 

228

 

944

 

918

Merchandise

226

 

230

 

875

 

897

Nutrien Financial

82

 

77

 

376

 

361

Nutrien Financial elimination 1

(23)

 

(16)

 

(93)

 

(103)

 

3,144

 

3,179

 

17,620

 

17,832

Potash sales by geography

 

 

 

 

 

 

 

Manufactured product

 

 

 

 

 

 

 

North America

278

 

245

 

1,727

 

1,719

Offshore 2

514

 

342

 

2,264

 

1,658

Other potash and purchased products

 

 

4

 

1

 

792

 

587

 

3,995

 

3,378

Nitrogen sales by product line

 

 

 

 

 

 

 

Manufactured product

 

 

 

 

 

 

 

Ammonia

319

 

376

 

1,218

 

1,232

Urea and ESN®

360

 

395

 

1,648

 

1,480

Solutions, nitrates and sulfates

424

 

339

 

1,641

 

1,300

Other nitrogen and purchased products 3

137

 

33

 

232

 

122

 

1,240

 

1,143

 

4,739

 

4,134

Phosphate sales by product line

 

 

 

 

 

 

 

Manufactured product

 

 

 

 

 

 

 

Fertilizer

362

 

309

 

1,275

 

1,237

Industrial and feed

177

 

157

 

661

 

627

Other phosphate and purchased products

4

 

5

 

22

 

24

 

543

 

471

 

1,958

 

1,888

1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

2 Relates to Canpotex Limited ("Canpotex") (see Note 10) and includes provisional pricing adjustments for the three months ended December 31, 2025 of $3 million (2024 – $(3) million) and the twelve months ended December 31, 2025 of $48 million (2024 – $4 million).

3 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

Note 3 Impairment of assets

During the three and twelve months ended December 31, 2025, we assessed our assets for indicators of impairment. No impairment was recognized during the year.

Nitrogen

At December 31, 2025, circumstances within our Trinidad cash generating unit (CGU) presented an indicator of impairment. On October 23, 2025, the Trinidad nitrogen facility completed a controlled shutdown in response to port access restrictions imposed by Trinidad and Tobago’s National Energy Corporation and a lack of reliable and economic natural gas supply. As a result, we performed impairment testing on our Trinidad CGU, part of our Nitrogen segment. No impairment was recognized, as the recoverable amount of the Trinidad CGU exceeded its carrying amount. The recoverable amount was determined using a fair value less costs of disposal (“FVLCD”) methodology. The valuation was based on post-tax discounted cash flows using a 10-year projection and a 2.0% terminal growth rate discounted at a post-tax rate of 11.8%.

Goodwill impairment testing

As at December 31 ($ millions)

2025

 

2024

Goodwill by CGU or Group of CGUs

 

 

 

Retail – North America

7,006

 

6,961

Retail – Australia

587

 

539

Potash

154

 

154

Nitrogen

4,389

 

4,389

 

12,136

 

12,043

During the three and twelve months ended December 31, 2025, we performed our annual impairment test on goodwill and did not identify any impairment.

In testing for impairment of goodwill, we calculate the recoverable amount for a CGU or groups of CGUs containing goodwill. We used the FVLCD methodology based on post-tax discounted cash flows (five-year or 10-year projections plus a terminal value) and incorporated assumptions an independent market participant would apply. We adjusted discount rates for each CGU or group of CGUs for the risk associated with achieving our forecasts and for the country risk premium in which we expect to generate cash flows. FVLCD is a Level 3 measurement. We use our market capitalization (where applicable) and comparative market multiples to ensure discounted cash flow results are reasonable.

The key assumptions with the greatest influence on the calculation of the recoverable amounts are the discount rates, terminal growth rates and forecasted EBITDA. The key forecast assumptions were based on historical data and our estimates of future results from internal sources considering industry and market information.

Retail – North America CGU

During our performance of our annual impairment test, the Retail – North America group of CGUs recoverable amount exceeded its carrying amount by $2.9 billion. Goodwill is more susceptible to impairment risk if there is an increase in the discount rate or a deterioration in business operating results or economic conditions and actual results do not meet our forecasts. A reduction in the terminal growth rate, an increase in the discount rate or a decrease in forecasted EBITDA could cause impairment in the future as shown in the table below.

 

 

Key assumption

 

Change required for carrying amount

2025 Annual impairment testing

 

used in impairment model

 

to equal recoverable amount

Terminal growth rate (%)

 

2.3

 

1.8

Percentage point decrease

Discount rate 1 (%)

 

7.7

 

1.2

Percentage point increase

Forecasted EBITDA over forecast period ($ millions)

 

8,500

 

12

Percent decrease

1 The discount rate used in the previous measurement at October 1, 2024 was 7.3 percent.

Retail – Australia, Potash, and Nitrogen CGUs

The following table indicates the key assumptions used in testing the remaining groups of CGUs:

 

Terminal growth rate (%)

 

Post-tax discount rate (%)

 

2025

 

2024

 

2025

 

2024

Retail – Australia

2.5

 

2.6

 

7.6

 

7.9

Potash

2.0

 

2.5

 

7.3

 

6.3

Nitrogen

2.0

 

2.3

 

8.7

 

7.6

2024 Impairment of assets

In the twelve months ended December 31, 2024, we recorded the following non-cash impairment of assets in the condensed consolidated statements of earnings:

 

 

 

($ millions)

 

December 31, 2024

Segment

Category

 

 

Retail

Intangible assets

 

200

 

Property, plant and equipment

 

120

 

Other

 

15

Nitrogen

Property, plant and equipment

 

195

Impairment of assets

 

530

Note 4 Other expenses (income)

 

Three Months Ended

 

Twelve Months Ended

 

December 31

 

December 31

($ millions)

2025

 

2024

 

2025

 

2024

Restructuring costs

46

 

47

 

68

 

47

Earnings of equity-accounted investees

(1)

 

(23)

 

(37)

 

(130)

Bad debt (recovery) expense

(3)

 

23

 

85

 

117

Project feasibility costs

39

 

26

 

108

 

92

Customer prepayment costs

13

 

12

 

63

 

58

Legal expenses

8

 

15

 

21

 

47

ARO/ERL related expenses (income) for non-operating sites 1

9

 

(1)

 

2

 

151

Loss on natural gas derivatives not designated as a hedge

 

1

 

 

8

Loss related to financial instruments in Argentina

 

1

 

 

35

Insurance recoveries

 

(3)

 

(1)

 

(65)

Other expenses

66

 

31

 

139

 

53

 

177

 

129

 

448

 

413

1 ARO/ERL refers to asset retirement obligations and accrued environmental costs.

Note 5 Income taxes

 

Three Months Ended

 

Twelve Months Ended

 

December 31

 

December 31

($ millions, except as otherwise noted)

2025

 

2024

 

2025

 

2024

Actual effective tax rate on earnings (%)

21

 

33

 

24

 

40

Actual effective tax rate including discrete items (%)

22

 

42

 

25

 

38

Discrete tax adjustments that impacted the tax rate 1

4

 

18

 

27

 

(13)

1 Discrete tax adjustments arise from specific, significant or unusual events that are recognized in the period in which the event occurs, rather than being allocated across the year through the annual effective tax rate.

Note 6 Investments

 

 

 

 

 

Proportion of

Ownership Interest and

 

 

 

 

 

 

 

 

Voting Rights Held (%)

 

Carrying Amount

($ millions, except as otherwise noted)

Principal
Activity

 

Principal
Place of
Business and
Incorporation

 

As at
December 31,
2025

As at
December 31,
2024

 

As at
December 31,
2025

As at
December 31,
2024

Equity-accounted investees

 

 

 

 

 

 

 

 

Profertil S.A. ("Profertil")

Nitrogen producer

 

Argentina

 

50

 

349

Canpotex

Marketing and

logistics of potash

 

Canada

 

50

50

 

Other associates and joint ventures

 

 

 

 

 

 

134

128

Total equity-accounted investees

 

 

 

 

 

 

134

477

Investments at FVTOCI

 

 

 

 

 

Sinofert Holdings Limited ("Sinofert")

Fertilizer supplier

and distributor

 

China/Bermuda

 

19

 

211

Other

 

 

 

 

 

 

 

10

10

Total investments at FVTOCI

 

 

 

 

 

 

10

221

Total investments

 

 

 

 

 

 

144

698

Equity-accounted investees

In 2025, as part of our strategic priority to simplify and focus, we entered into an agreement to sell our 50 percent equity ownership in Profertil, which had been classified as an equity-accounted investment. A deposit of $120 million was received from the purchaser on September 5, 2025. The sale closed on December 10, 2025 resulting in gross proceeds of $595 million and a gain of $301 million recorded in the consolidated statement of earnings within our Corporate and Others segment. This gain reflects the difference between the net proceeds and the carrying amount of the investment at the date of sale. The buyer remitted the applicable withholding tax on behalf of Nutrien, resulting in a $60 million non-cash transaction.

Investments at fair value through other comprehensive income

In 2025, as part of our strategic priority to simplify and focus, we fully divested our remaining equity ownership interest in Sinofert, which had been classified as a financial asset measured at fair value through other comprehensive income. Gross proceeds from the sale were $193 million and reflected the fair value of the investment at the date of derecognition. A fair value loss of $18 million related to the investment was recognized in other comprehensive income. Upon derecognition, the cumulative unrealized gain previously recognized in other comprehensive income of $27 million was reclassified to retained earnings.

Note 7 Financial instruments

Foreign currency derivatives

 

Three Months Ended

 

Twelve Months Ended

 

December 31

 

December 31

($ millions)

2025

 

2024

 

2025

 

2024

Foreign exchange loss (gain)

7

 

(13)

 

(2)

 

14

Hyperinflationary loss 1

 

12

 

 

97

(Gain) loss on foreign currency derivatives at fair value through profit or loss ("FVTPL")

(16)

 

2

 

11

 

249

Foreign exchange (gain) loss, net of related derivatives

(9)

 

1

 

9

 

360

1 In 2025, the functional currency of our Argentina operations changed from the Argentine peso to the US dollar and was applied prospectively from the date of change, eliminating the need for hyperinflationary adjustments.

Our financial instruments carrying amounts are a reasonable approximation of their fair values, except for our long-term debt, including current portion, that has a carrying value of $9,863 million and fair value of $9,476 million as at December 31, 2025. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.

Note 8 Debt

In 2025, we extended the maturity of our $4,500 million unsecured committed revolving term facility to September 4, 2030. We also extended the term of our unsecured committed revolving term credit facility to September 2, 2026 and reduced the facility limit from $750 million to $500 million.

($ millions, except as otherwise noted)

Rate of interest (%)

 

Maturity

 

Amount

Senior notes repaid in 2025

3.000

 

April 1, 2025

 

500

Senior notes repaid in 2025

5.950

 

November 7, 2025

 

500

 

 

 

 

 

1,000

 

 

 

 

 

 

Senior notes issued in 2025

4.500

 

March 12, 2027

 

400

Senior notes issued in 2025

5.250

 

March 12, 2032

 

600

 

 

 

 

 

1,000

The senior notes issued in the twelve months ended December 31, 2025, are unsecured, rank equally with our existing unsecured debt, and have no sinking fund requirements prior to maturity. Each series of outstanding senior notes is redeemable and has various provisions for redemption prior to maturity, at our option, at specified prices.

Note 9 Share capital

Share repurchase programs

The following table summarizes our share repurchase activities during the periods indicated below:

 

Three Months Ended

 

Twelve Months Ended

 

December 31

 

December 31

($ millions, except as otherwise noted)

2025

 

2024

 

2025

 

2024

Number of common shares repurchased for cancellation

2,540,498

 

2,905,718

 

9,829,408

 

3,944,903

Average price per share (US dollars)

58.76

 

47.02

 

55.94

 

47.31

Total cost, inclusive of tax

151

 

139

 

560

 

190

Subsequent to December 31, 2025, as of February 17, 2026, an additional 1,097,694 common shares were repurchased for cancellation at a cost of $73 million and an average price per share of $66.97.

On February 18, 2026, our Board of Directors approved a share repurchase program for up to five percent of our outstanding common shares. The 2026 normal course issuer bid, which is subject to the acceptance by the Toronto Stock Exchange, will expire after a 12-month period, if we acquire the maximum number of common shares allowable or otherwise decide not to make any further repurchases.

Dividends declared

We declared a dividend per share of $0.545 (2024 – $0.54) during the three months ended December 31, 2025, payable on January 16, 2026 to shareholders of record on December 31, 2025.

On February 18, 2026, our Board of Directors declared and increased our quarterly dividend to $0.55 per share payable on April 16, 2026, to shareholders of record on March 31, 2026. The total estimated dividend to be paid is $265 million.

Note 10 Related party transactions

We sell potash outside Canada and the US exclusively through Canpotex. Our total revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. The receivable outstanding from Canpotex arose from sale transactions described above. It is unsecured and bears no interest. Any credit losses held against this receivable are expected to be negligible. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed-upon prices. Purchases from Canpotex for the three months ended December 31, 2025 were $50 million (2024 – $34 million) and the twelve months ended December 31, 2025 were $150 million (2024 – $146 million).

 

 

As at

 

As at

($ millions)

 

December 31, 2025

 

December 31, 2024

Receivables from Canpotex

 

279

 

122

Payables to Canpotex

 

63

 

66

Note 11 Accounting policies, estimates and judgments

Amendments to IFRS 9 and IFRS 7, Classification and Measurement of Financial Instruments, issued in May 2024, describe the timing of recognition and derecognition for a financial asset or financial liability, including clarifying that a financial liability is derecognized on the settlement date. In addition to these clarifications, the amendments introduce an accounting policy choice to derecognize financial liabilities settled using an electronic payment system before the settlement date if specific conditions are met. These amendments will be effective January 1, 2026, and will not apply to comparative information. Nutrien has reviewed its banking procedures and assessed that the impact of the amendment is immaterial as at January 1, 2026.

IFRS 18, Presentation and Disclosure in Financial Statements, issued in April 2024, would replace IAS 1, Presentation of Financial Statements, and introduce new presentation requirements, including defined subtotals and enhances guidance on aggregation and disaggregation. IFRS 18 will be effective January 1, 2027, and will also apply to comparative information. We are reviewing the standard to determine the potential impact.

Contacts:

Investor Contact:
Jeff Holzman
Senior Vice President, Investor Relations and FP&A
(306) 933-8545 – investors@nutrien.com

Media Contact:
Simon Scott
Vice President, Global Communications
(403) 225-7213 – media@nutrien.com

Source: Nutrien Ltd.

© 2026 Canjex Publishing Ltd. All rights reserved.